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Synthesis of 15 Amino Acid Gtp-Ase Binding Region of Tuberous Sclerosis
2 to Study its Interaction with the Ras Gtp-Ase Rheb
Sigrid L. Johannesen.
Tuberous sclerosis 2 (TSC2) is a gene in the human body associated with be-
nign tumorigenesis. TSC2 activates Rheb (Ras homology enriched in brain)
protein, causing cell growth and production. An improper interaction of
TSC2 with the Rheb protein has been shown to have these disease-causing
effects. Rheb protein is a member of the Ras (Raus Sarcoma) family of proteins
and is connected to cell growth, energy, and nutrient levels. The study of the
improper interaction between TSC2 and Rheb has not been fully explored,
and would lead to advances in treatment and prevention of this disease.
One obstacle in the study of the interaction between TSC2 and Rheb is the
size of the TSC2 protein. TSC2 is an 1807 amino acid protein, which makes
in-vitro characterization difficult. Thus, a smaller, representative region of
the GTPase-binding domain of TSC2 must be synthesized in order for fur-
ther exploration to take place. It has been determined that a 15 amino
acid region of the TSC2 protein could be the site of the interaction with
Rheb. In order to study the interaction of Rheb with this 15 amino acid pep-
tide, the peptide was synthesized, along with several mutant peptides. Once
these peptides were synthesized, their binding affinities for Rheb were mea-
sured using Isothermal Titration Calorimetry. In addition, a determination
can be made as to each peptide’s stabilizing effects on the TSC2-Rheb com-
plex. Significant additions to the stability of this complex could lead to
a decrease or elimination of the over-active Rheb signaling which leads to
benign tumorigenesis.
284-Pos Board B84
Time-Integrated Fluorescence Cumulant Analysis (TIFCA) Enables
Model Selection in Ligand Binding Studies
Joseph P. Skinner, Bin Wu, Joachim D. Mueller, Sergey Y. Tetin.
TIFCA is a fluorescence fluctuation spectroscopy technique that makes use of
both the molecular brightness and diffusion time of freely diffusing fluores-
cent species. TIFCA was introduced to calculate statistically significant higher
order cumulants to accurately describe protein interactions using rigorous fit-
ting procedures. Previously, we have applied TIFCA to perform a titration,
confirm antibody stoichiometry and measure the binding affinity by first as-
suming a bivalent antibody model. The cumulants were calculated up to forth
order and globally fit to resolve the fraction of bound and unbound ligand. The
global fitting routine uses all points in the titration simultaneously and returns
a global reduced chi2 for the entire titration series. It was found that analysis
of the global reduced chi2 alone is not sensitive to the chosen binding model.
Here we show that TIFCA has the ability to determine proper binding models
by evaluating fits to individual cumulants within the titration series. Using
a small peptide and antibody, we show that local reduced chi2 values are
rather high for expressions describing a monovalent antibody. Only the cor-
rect number of species describing the bivalent nature of antibodies results
in acceptable local reduced chi2 values for all orders of cumulants. More spe-
cifically, it is found that the second order cumulant is highly dependent upon
the number of binding sites in an antibody molecule leading to the correct
binding model.
J.D.M. acknowledges support from the National Institute of Health
(GM64589).
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Design of a Duet Expression Vector to Characterize Ligand-receptor
Interactions
Nicholas D. Tingquist, Anna E. Daily, Alicia Kight,
Thallapuranam Krishnaswamy Suresh Kumar.
One major challenge in the expression and purification of recombinant proteins
is preventing proteins from forming inclusion bodies. Recovery of proteins
from inclusion bodies can be laborious, and often a futile exercise. The partition
between productive folding and non-specific aggregation/inclusion body for-
mation is believed to be a competition between non-specific and specific struc-
tural interactions. Aggregation/inclusion body formation can be thwarted by
promoting conditions that facilitate specific interactions during folding of the
polypeptide chain.
D2 module of the extracellular immunoglobulin-like domain of the fibro-
blast growth factor (FGF) is overexpressed in Escherichia coli as inclusion
bodies. Urea denaturation of inclusion bodies, and subsequent refolding, re-
sults in meager yields of the recombinant protein. In addition, the ‘‘nativ-
ity’’ of the refolded recombinant D2 module is always questionable. In this
context, we have designed a novel Duet vector that co-expresses the D2module and the ligand (FGF) simultaneously. It is predicted that the recep-
tor module and FGF will form a soluble binary complex which can be dis-
sociated under high salt conditions to simultaneously yield pure
recombinant D2 module and FGF. Using the purified recombinant proteins,
the structure of the FGF-receptor complex will be characterized using a va-
riety of biophysical experiments, including multidimensional NMR spec-
troscopy.
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A Structural Based Design of a Novel Protein Affinity Tag for Purification
of Recombinant Proteins
Srinivas Jayanthi, Suresh Thallapuranam.
Fibroblast growth factors (FGFs) are a family of heparin binding proteins that
are involved in the regulation of key cellular processes such as cell prolifera-
tion, cell differentiation, wound healing, angiogenesis, and tumor growth.
The present study is focused on the characterization of a novel heparin binding
peptide (HEP-pep) designed based on the comparison of the available struc-
tures of FGF and other heparin binding proteins. Results of the isothermal titra-
tion calorimetry experiments show that HEP-pep binds to heparin with
nanomolar affinity (Kd ~ 150 nM). Far UV CD spectrum of HEP-pep suggests
that the peptide is predominantly in a random coil conformation. However, the
peptide is observed to fold in to a helical conformation on binding to heparin.
Steady state fluorescence experiments suggest that HEP-pep binds to heparin in
a 1:1 stoichiometry. Conformational changes monitored by 1H-15N HSQC
spectra of HEP-pep, in the absence and presence of heparin, shows a dramatic
increase in the dispersion of the 1H-15N crosspeaks in the presence of heparin.
Chemical shift index plot (based on Ha chemical shifts) shows that a conforma-
tional switch, from disordered state(s) to a helix, occurs in the HEP-pep on
binding to heparin.
Based on the structural information on the HEP-pep, a recombinant vector was
constructed and several target proteins with HEP-pep tag at N-terminus were
overexpressed in high yields in E.coli. The HEP-pep fused target proteins
were successfully purified to homogeneity in a single step on heparin sephar-
ose. In addition, the HEP-pep tag does not appear to interfere with the folding
of the target proteins. The details of the structure of the HEP-pep and its effi-
cacy as an affinity tag for purification of recombinant proteins will be pre-
sented.
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Determination of the Volume Changes Induced by Ligand Binding to
Hsp90 Using High Pressure Denaturation
Daumantas Matulis.
The volume changes accompanying ligand
binding to proteins are thermodynamically
important and could be used in the design
of compounds with specific binding prop-
erties. Measuring the volumetric properties
could yield as much information, as the en-
thalpic properties of binding. Pressure-
based methods are significantly more
laborious than temperature methods and
are underused. Here, we present a pressure shift assay (PressureFluor, analogous
to the ThermoFluor, thermal shift assay) that uses high pressure to denature pro-
teins. The PressureFluor method was used to study the ligand binding thermody-
namics of heat shock protein 90 (Hsp90).
Increased concentration of a ligand caused the shift in the Pm as shown in the
Figure. The volumes of the protein in the absence and presence of several li-
gands were determined. The compressibilities of the system could be also de-
termined with significantly lower precision than the volumes. The formulas
describing the relationship between the added ligand concentration and the
Pm were derived and will be presented.
288-Pos Board B88
Evolution of the Effect of Arginine on Thermal Stability and Oligomeriza-
tion of N-Acetylglutamate Synthase
Ljubica Caldovic, Nantaporn Haskins, Amy Mumo, Mendel Tuchman,
Hiroki Morizono.
N-acetylglutamate synthase (NAGS; E.C.2.3.1.1) catalyzes the formation of
N-acetylglutamate (NAG) from acetyl coenzyme A and glutamate. In micro-
organisms and plants, NAG is the first intermediate of arginine biosynthesis
pathway, while in animals, NAG acts as an allosteric activator of carbamyl-
phosphate synthetase I and III. NAGS itself is allosterically regulated by argi-
nine. In bacteria, fungi, and plants, arginine acts as an inhibitor, in fish,
